555 related articles for article (PubMed ID: 29880106)
1. Incidence and Outcomes of Positive Bubble Contrast Study Results After Transcatheter Closure of a Patent Foramen Ovale.
Shah AH; Osten M; Benson L; Alnasser S; Bach Y; Vishwanath R; Van De Bruaene A; Shulman H; Navaranjan J; Khan R; Horlick E
JACC Cardiovasc Interv; 2018 Jun; 11(11):1095-1104. PubMed ID: 29880106
[TBL] [Abstract][Full Text] [Related]
2. Residual Shunt after Patent Foramen Ovale Device Closure in Patients With Cryptogenic Stroke: Serial Bubble Contrast Transesophageal Echocardiography Data.
Moon J; Kim M; Oh PC; Shin DH; Park HM; Jo YY; Lee JS; Kang WC
J Stroke Cerebrovasc Dis; 2019 Feb; 28(2):347-353. PubMed ID: 30396838
[TBL] [Abstract][Full Text] [Related]
3. Residual shunt after percutaneous closure of patent foramen ovale with AMPLATZER occluder devices - influence of anatomic features: a transcranial Doppler and intracardiac echocardiography study.
Marchese N; Pacilli MA; Inchingolo V; Fanelli R; Loperfido F; Vigna C
EuroIntervention; 2013 Jul; 9(3):382-8. PubMed ID: 23872652
[TBL] [Abstract][Full Text] [Related]
4. The Case for Selective Patent Foramen Ovale Closure After Cryptogenic Stroke.
Wiktor DM; Carroll JD
Circ Cardiovasc Interv; 2018 Mar; 11(3):e004152. PubMed ID: 29870380
[TBL] [Abstract][Full Text] [Related]
5. Comparison of residual shunt rate and complications across 6 different closure devices for patent foramen ovale.
Gevorgyan Fleming R; Kumar P; West B; Noureddin N; Rusheen J; Aboulhosn J; Tobis JM
Catheter Cardiovasc Interv; 2020 Feb; 95(3):365-372. PubMed ID: 31654558
[TBL] [Abstract][Full Text] [Related]
6. Percutaneous patent foramen ovale closure: outcomes with the Premere and Amplatzer devices.
Bissessor N; Wong AW; Hourigan LA; Jayasinghe RS; Scalia GS; Burstow DJ; Griffiths LR; Savage M; Walters DL
Cardiovasc Revasc Med; 2011; 12(3):164-169. PubMed ID: 21640934
[TBL] [Abstract][Full Text] [Related]
7. Diagnosis of secondary source of right-to-left shunt with balloon occlusion of patent foramen ovale and power M-mode transcranial Doppler.
Jesurum JT; Fuller CJ; Renz J; Krabill KA; Spencer MP; Reisman M
JACC Cardiovasc Interv; 2009 Jun; 2(6):561-7. PubMed ID: 19539262
[TBL] [Abstract][Full Text] [Related]
8. Medium-term results of transcatheter closure of patent foramen ovale (PFO) with Amplatzer PFO and Cribriform occluders.
Białkowski J; Wawrzyńczyk M; Karwot B; Fiszer R; Knop M; Szkutnik M
Kardiol Pol; 2012; 70(11):1142-6. PubMed ID: 23180522
[TBL] [Abstract][Full Text] [Related]
9. Management of residual shunts after initial percutaneous patent foramen ovale closure: a single center experience with immediate and long-term follow-up.
Diaz T; Cubeddu RJ; Rengifo-Moreno PA; Cruz-Gonzalez I; Solis-Martin J; Buonanno FS; Inglessis I; Palacios IF
Catheter Cardiovasc Interv; 2010 Jul; 76(1):145-50. PubMed ID: 20578100
[TBL] [Abstract][Full Text] [Related]
10. Sensitivity of transcranial Doppler versus intracardiac echocardiography in the detection of right-to-left shunt.
Van H; Poommipanit P; Shalaby M; Gevorgyan R; Tseng CH; Tobis J
JACC Cardiovasc Imaging; 2010 Apr; 3(4):343-8. PubMed ID: 20394894
[TBL] [Abstract][Full Text] [Related]
11. Long-term follow-up after PFO device closure: Outcomes and Complications in a Single-center Experience.
Taggart NW; Reeder GS; Lennon RJ; Slusser JP; Freund MA; Cabalka AK; Cetta F; Hagler DJ
Catheter Cardiovasc Interv; 2017 Jan; 89(1):124-133. PubMed ID: 27027873
[TBL] [Abstract][Full Text] [Related]
12. Efficiency of transcatheter patent foramen ovale closure in children after paradoxical embolism events.
Wawrzyńczyk M; Gałeczka M; Karwot B; Knop M; Białkowski J
Kardiol Pol; 2016; 74(4):385-9. PubMed ID: 26412471
[TBL] [Abstract][Full Text] [Related]
13. Echocardiographic findings in simple and complex patent foramen ovale before and after transcatheter closure.
Vitarelli A; Mangieri E; Capotosto L; Tanzilli G; D'Angeli I; Toni D; Azzano A; Ricci S; Placanica A; Rinaldi E; Mukred K; Placanica G; Ashurov R
Eur Heart J Cardiovasc Imaging; 2014 Dec; 15(12):1377-85. PubMed ID: 25139906
[TBL] [Abstract][Full Text] [Related]
14. Transcatheter Closure of Patent Foramen Ovale versus Medical Therapy after Cryptogenic Stroke: A Meta-Analysis of Randomized Controlled Trials.
Darmoch F; Al-Khadra Y; Soud M; Fanari Z; Alraies MC
Cerebrovasc Dis; 2018; 45(3-4):162-169. PubMed ID: 29597192
[TBL] [Abstract][Full Text] [Related]
15. Long-term outcomes of patent foramen ovale closure or medical therapy after cryptogenic stroke: A meta-analysis of randomized trials.
Abdelaziz HK; Saad M; Abuomara HZ; Nairooz R; Pothineni NVK; Madmani ME; Roberts DH; Mahmud E
Catheter Cardiovasc Interv; 2018 Jul; 92(1):176-186. PubMed ID: 29726616
[TBL] [Abstract][Full Text] [Related]
16. Interventional closure of patent foramen ovale with Nit-occlud® device in prevention of recurrent neurologic events-Long-term results.
Araszkiewicz A; Sławek S; Trojnarska O; Lesiak M; Grygier M
Catheter Cardiovasc Interv; 2018 Jul; 92(1):159-164. PubMed ID: 29068141
[TBL] [Abstract][Full Text] [Related]
17. Cryptogenic Stroke and High-Risk Patent Foramen Ovale: The DEFENSE-PFO Trial.
Lee PH; Song JK; Kim JS; Heo R; Lee S; Kim DH; Song JM; Kang DH; Kwon SU; Kang DW; Lee D; Kwon HS; Yun SC; Sun BJ; Park JH; Lee JH; Jeong HS; Song HJ; Kim J; Park SJ
J Am Coll Cardiol; 2018 May; 71(20):2335-2342. PubMed ID: 29544871
[TBL] [Abstract][Full Text] [Related]
18. Long-term transesophageal echocardiography after patent foramen ovale closure by BioSTAR and Amplatzer patent foramen ovale occluders.
Suligoj NC; Rojko M; Suligoj B; Zorc M; Kar S; Noc M
Catheter Cardiovasc Interv; 2020 Feb; 95(3):349-354. PubMed ID: 31131978
[TBL] [Abstract][Full Text] [Related]
19. Predictors of recurrent events in patients with cryptogenic stroke and patent foramen ovale within the CLOSURE I (Evaluation of the STARFlex Septal Closure System in Patients With a Stroke and/or Transient Ischemic Attack Due to Presumed Paradoxical Embolism Through a Patent Foramen Ovale) trial.
Elmariah S; Furlan AJ; Reisman M; Burke D; Vardi M; Wimmer NJ; Ling S; Chen X; Kent DM; Massaro J; Mauri L;
JACC Cardiovasc Interv; 2014 Aug; 7(8):913-20. PubMed ID: 25147037
[TBL] [Abstract][Full Text] [Related]
20. Multidisciplinary assessment of PFO with substantial right-to-left shunting and medium-term follow-up after PFO device closure: A single-center experience.
He L; Cheng GS; Du YJ; Zhang YS
J Interv Cardiol; 2017 Aug; 30(4):362-367. PubMed ID: 28568903
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]